Market Overview

First Solar, Intermolecular Extend, Expand Licensing Deal

Share:
Related IMI
9 Most Shorted ETFs In The Market
18 Biggest Mid-Day Losers For Friday
Related FSLR
50 Biggest Movers From Friday
Mid-Afternoon Market Update: NASDAQ Gains Over 2%; Expedia Shares Slide On Downbeat Earnings

Intermolecular, Inc. (Nasdaq: IMI) and First Solar, Inc. (Nasdaq: FSLR) today announced they have entered into a two-year collaboration and licensing agreement focused on further increases to the conversion efficiency of First Solar's cadmium telluride (CdTe) solar cell technology. Under the new collaborative development program, First Solar and Intermolecular researchers will work together to develop disruptive new approaches to increasing the performance of CdTe solar cell technology using Intermolecular's proprietary High Productivity Combinatorial (HPC™) platform. The program targets substantial gains in First Solar's module conversion efficiency beyond its previously announced roadmap.

Posted-In: News

 

Related Articles (FSLR + IMI)

View Comments and Join the Discussion!

Partner Center